Co-Diagnostics, Inc. (CODX) › RevenueCo-Diagnostics, Inc. (CODX) — RevenueAnnual figures by period end, from SEC filings.2017-12-31: $7.7K2018-12-31: $39.9K2019-12-31: $215.0K2020-12-31: $74.55M2021-12-31: $97.89M2022-12-31: $34.22M2023-12-31: $6.81M2024-12-31: $3.92M2025-12-31: $622.5K$622.5K2017-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$622.5K-84.1%2026-03-31From 2025-01-012024-12-31$3.92M-42.5%2026-03-31From 2024-01-012023-12-31$6.81M-80.1%2025-03-27From 2023-01-012022-12-31$34.22M-65.0%2024-03-14From 2022-01-012021-12-31$97.89M+31.3%2023-03-16From 2021-01-012020-12-31$74.55M+34579.9%2022-03-24From 2020-01-012019-12-31$215.0K+438.6%2021-03-25From 2019-01-012018-12-31$39.9K+420.9%2020-03-30From 2018-01-012017-12-31$7.7K—2019-04-01From 2017-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)